FDA cleared the Syneris PACS v.1.0.1.0 from Syneris on Sep 23, 2026 under K261874, a traditional 510(k). The device falls under product code LLZ, System, Image Processing, Radiological, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Jun 5, 2026. The decision came 110 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Syneris in the last 12 months of the tracker.